Skip to main content

ADVERTISEMENT

veliparib

Research in Review
12/06/2016
JCP Editors
Tobacco users with non-small cell lung cancer (NSCLC) have genetic alterations in their tumors that may underlie their increased responsiveness to veliparib, according to new research. ----- Related...
Tobacco users with non-small cell lung cancer (NSCLC) have genetic alterations in their tumors that may underlie their increased responsiveness to veliparib, according to new research. ----- Related...
...
12/06/2016
Journal of Clinical Pathways